Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III
Language English Country England, Great Britain Media print
Document type Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
Grant support
Intramural NIH HHS - United States
PubMed
19678840
DOI
10.1111/j.1742-4658.2009.07152.x
PII: EJB7152
Knihovny.cz E-resources
- MeSH
- Antigens, Surface chemistry MeSH
- Phosphopeptides chemistry MeSH
- Glutamate Carboxypeptidase II chemistry MeSH
- Carboxypeptidases chemistry MeSH
- Catalytic Domain MeSH
- Protein Conformation MeSH
- Crystallography, X-Ray MeSH
- Protein Structure, Quaternary MeSH
- Quisqualic Acid chemistry MeSH
- Glutamic Acid chemistry MeSH
- Humans MeSH
- Ligands MeSH
- Molecular Mimicry MeSH
- Binding Sites MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Intramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
- Names of Substances
- Antigens, Surface MeSH
- FOLH1 protein, human MeSH Browser
- Phosphopeptides MeSH
- Glutamate Carboxypeptidase II MeSH
- Carboxypeptidases MeSH
- Quisqualic Acid MeSH
- Glutamic Acid MeSH
- Ligands MeSH
- NAALAD2 protein, human MeSH Browser
Glutamate carboxypeptidase III (GCPIII) is a metalloenzyme that belongs to the transferrin receptor/glutamate carboxypeptidase II (GCPII; EC 3.4.17.21) superfamily. GCPIII has been studied mainly because of its evolutionary relationship to GCPII, an enzyme involved in a variety of neuropathologies and malignancies, such as glutamatergic neurotoxicity and prostate cancer. Given the potential functional and pharmacological overlap between GCPIII and GCPII, studies addressing the structural and physiological properties of GCPIII are crucial for obtaining a deeper understanding of the GCPII/GCPIII system. In the present study, we report high-resolution crystal structures of the human GCPIII ectodomain in a 'pseudo-unliganded' state and in a complex with: (a) L-glutamate (a product of hydrolysis); (b) a phosphapeptide transition state mimetic, namely (2S,3'S)-{[(3'-amino-3'-carboxy-propyl)-hydroxyphosphinoyl]methyl}-pentanedioic acid; and (c) quisqualic acid, a glutamate biostere. Our data reveal the overall fold and quaternary arrangement of the GCPIII molecule, define the architecture of the GCPIII substrate-binding cavity, and offer an experimental evidence for the presence of Zn(2+) ions in the bimetallic active site. Furthermore, the structures allow us to detail interactions between the enzyme and its ligands and to characterize the functional flexibility of GCPIII, which is essential for substrate recognition. A comparison of these GCPIII structures with the equivalent GCPII complexes reveals differences in the organization of specificity pockets, in surface charge distribution, and in the occupancy of the co-catalytic zinc sites. The data presented here provide information that should prove to be essential for the structurally-aided design of GCPIII-specific inhibitors and might comprise guidelines for future comparative GCPII/GCPIII studies.
References provided by Crossref.org
Uncovering the essential roles of glutamate carboxypeptidase 2 orthologs in Caenorhabditis elegans
Characterization of glutamate carboxypeptidase 2 orthologs in trematodes
Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer